IQVIA
IQV
#746
Rank
NZ$57.74 B
Marketcap
NZ$345.96
Share price
-1.12%
Change (1 day)
29.92%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2026 (TTM): NZ$4.02 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$16.63 Billion. In 2025 the company made an earning of NZ$3.98 Billion a decrease over its 2024 earnings that were of NZ$4.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$4.02 B1.05%
2025 NZ$3.98 B-0.81%
2024 NZ$4.01 B9.76%
2023 NZ$3.65 B19.79%
2022 NZ$3.05 B18.36%
2021 NZ$2.57 B90.49%
2020 NZ$1.35 B-1.25%
2019 NZ$1.37 B7.68%
2018 NZ$1.27 B6.61%
2017 NZ$1.19 B11.74%
2016 NZ$1.06 B-2.79%
2015 NZ$1.09 B6.31%
2014 NZ$1.03 B34.96%
2013 NZ$0.76 B11.16%
2012 NZ$0.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.71 Million-100.09% Bahamas
NRC Health
NRC
NZ$47.31 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA